Brain, Vol. 122, No. 8, 1597-1598,
August 1999
© 1999 Oxford University Press
Letter to the Editor |
Getting a grasp on research: does treatment taint testing of parkinsonian patients?
1 Department of Biobehavioral Sciences, Teachers College, and 2 Department of Rehabilitation Medicine, College of Physicians and Surgeons, Columbia University, New York, USA
Correspondence to:
Andrew M. Gordon, Department of Biobehavioral Sciences, Teachers College, Columbia University, 525 West 120th Street, New York, NY 10027, USA
The study of motor behaviour in patients with Parkinson's disease whilst on medication is widespread. The reasoning behind this is simple: (i) patients typically come to neurology clinics in the medicated state, making on-site testing in this state convenient to many investigators; (ii) testing in the unmedicated state may pose a hardship for patients; (iii) patients in the advanced stages of the disease may be less inclined to participate whilst off medication, skewing the subject pool; and (iv) testing patients in the unmedicated state may raise liability concerns. While all these issues are legitimate, there appears to be a common misconception that while medication may limit the interpretation of negative findings (i.e. lack of differences between
References
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R. Wenzelburger, B.-R. Zhang, S. Pohle, S. Klebe, D. Lorenz, J. Herzog, H. Wilms, G. Deuschl, and P. Krack Force overflow and levodopa-induced dyskinesias in Parkinson's disease Brain, April 1, 2002; 125(4): 871 - 879. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. N. Lewis, W. D. Byblow, and S. E. Walt Stride length regulation in Parkinson's disease: the use of extrinsic, visual cues Brain, October 1, 2000; 123(10): 2077 - 2090. [Abstract] [Full Text] [PDF]
|
|